Renaud Buffet

Person

Vanves, FR

People

Patents Grantslast 30 patents

Information Patent Grant
Compound that specifically binds to KIR3DL2 for use in the treatmen...
- Patent number 12,084,498
- Issue date Sep 10, 2024
- Innate Pharma
- Cecile Bonnafous
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of peripheral T cell lymphoma
- Patent number 11,999,784
- Issue date Jun 4, 2024
- Innate Pharma
- Cécile Bonnafous
- G01 - MEASURING TESTING
Information Patent Grant
Compound that specifically binds to KIR3DL2 for use in the treatmen...
- Patent number 11,078,275
- Issue date Aug 3, 2021
- Innate Pharma
- Cecile Bonnafous
- G01 - MEASURING TESTING
Information Patent Grant
Treatment of peripheral T cell lymphoma
- Patent number 10,344,087
- Issue date Jul 9, 2019
- Innate Pharma
- Cécile Bonnafous
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compound that specifically binds to KIR3DL2 for use in the treatmen...
- Patent number 10,174,112
- Issue date Jan 8, 2019
- Innate Pharma
- Cecile Bonnafous
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for treatment of recurrent hematological malignancies
- Patent number 9,844,593
- Issue date Dec 19, 2017
- Innate Pharma S.A.
- Pascale Andre
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATMEN...
- Publication number 20210363248
- Publication date Nov 25, 2021
- Innate Pharma
- CECILE BONNAFOUS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF PERIPHERAL T CELL LYMPHOMA
- Publication number 20190315857
- Publication date Oct 17, 2019
- Innate Pharma
- CÉCILE BONNAFOUS
- G01 - MEASURING TESTING
Information Patent Application
COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATMEN...
- Publication number 20190127463
- Publication date May 2, 2019
- Innate Pharma
- CECILE BONNAFOUS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATMEN...
- Publication number 20170298132
- Publication date Oct 19, 2017
- Innate Pharma
- CECILE BONNAFOUS
- G01 - MEASURING TESTING
Information Patent Application
METHODS FOR RESTORING CORTICOSTEROID SENSITIVITY
- Publication number 20160136272
- Publication date May 19, 2016
- Innate Pharma
- RENAUD BUFFET
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATM...
- Publication number 20160002345
- Publication date Jan 7, 2016
- Innate Pharma
- CÉCILE BONNAFOUS
- G01 - MEASURING TESTING
Information Patent Application
TREATMENT OF PERIPHERAL T CELL LYMPHOMA
- Publication number 20150376274
- Publication date Dec 31, 2015
- Innate Pharma
- CÉCILE BONNAFOUS
- G01 - MEASURING TESTING
Information Patent Application
NK CELL MODULATING TREATMENTS AND METHODS FOR TREATMENT OF HEMATOLO...
- Publication number 20130251711
- Publication date Sep 26, 2013
- INNATE PHARMA SA
- Pascale Andre
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Renaud Buffet

Person

Patents Grantslast 30 patents

Compound that specifically binds to KIR3DL2 for use in the treatmen...

Treatment of peripheral T cell lymphoma

Compound that specifically binds to KIR3DL2 for use in the treatmen...

Treatment of peripheral T cell lymphoma

Compound that specifically binds to KIR3DL2 for use in the treatmen...

Methods for treatment of recurrent hematological malignancies

Patents Applicationslast 30 patents

COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATMEN...

TREATMENT OF PERIPHERAL T CELL LYMPHOMA

COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATMEN...

COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATMEN...

METHODS FOR RESTORING CORTICOSTEROID SENSITIVITY

A COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATM...

TREATMENT OF PERIPHERAL T CELL LYMPHOMA

NK CELL MODULATING TREATMENTS AND METHODS FOR TREATMENT OF HEMATOLO...